The present invention relates to the compounds of formula I as well as to their use as PIM kinase inhibitors and, thereby, their use for treating oncological diseases, particularly of the hematopoietic system, the liver and the prostate gland.
本发明涉及式I的化合物,以及它们作为
PIM激酶
抑制剂的用途,从而用于治疗肿瘤性疾病,特别是血液系统、肝脏和前列腺的肿瘤。